KV Pharmaceutical Co. agreed to buy exclusive U.S. rights to a spray-on hot flash treatment from Vivus Inc. for $150 million cash, the drug makers said Friday.
Internet NewsShare and Enjoy:These icons link to social bookmarking sites where readers can share and discover new web pages.
Original post by Steven Syre, Globe Columnist and software by Elliott Back
